RecallRadar
ModerateReported November 4, 2026 (2 weeks ago)

Theophylline Extended-Release Tablets, 100 mg, Rx Only

Recalled by Brandywine Pharmaceuticals, LLC

Drug recall

Brandywine Pharmaceuticals, LLC

Class II — moderate

Using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.

Brandywine Pharmaceuticals, LLC has recalled Theophylline Extended-Release Tablets, 100 mg, Rx Only, according to data published by the U.S. Food and Drug Administration (FDA). The recall was reported on November 4, 2026 and was initiated on October 6, 2026. It is classified as a Class II recall, which means using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.

Below is a plain-English summary of what was recalled, why it was recalled, how to tell whether you have the affected product, and what steps you can take. For the complete and most current details, you can view the FDA record linked further down this page.

What was recalled?

This recall covers Theophylline Extended-Release Tablets, 100 mg, Rx Only, with approximately 1,620 100-count bottles affected. The company behind the recall is Brandywine Pharmaceuticals, LLC, based in West Chester, PA. The FDA describes the product as: “Theophylline Extended-Release Tablets, 100 mg, Rx Only, 100-count bottle, Distributed by: Brandywine Pharmaceuticals, LLC, West Chester, PA 19382, NDC: 71321-500-10”

Why was Theophylline Extended-Release Tablets, 100 mg, Rx Only recalled?

According to the FDA, the stated reason for the recall is: “CGMP Deviations: interruption in the ongoing stability testing program conducted at a third-party laboratory.” In plain terms, this recall relates to a manufacturing quality issue (CGMP).

CGMP stands for Current Good Manufacturing Practice — the FDA's quality rules for how medicines must be made, tested, and documented. A CGMP-related recall means the manufacturing process did not meet those standards. It does not automatically mean the medicine is harmful, but the FDA cannot be confident in its quality, so it is removed from the market.

What should you do?

If you think you may have bought Theophylline Extended-Release Tablets, 100 mg, Rx Only, compare it against the product description and identifying codes (Lot: 405617, Expiry: 03/31/2028) before using it. This recall is currently listed as ongoing.

The general guidance for a matching product is to stop using it and follow the instructions in the official FDA recall notice, which may include a repair, replacement, refund, or safe disposal. When in doubt, contact Brandywine Pharmaceuticals, LLC or your local health authority.

About this recall

This recall was distributed in PA. RecallRadar summarizes recall information from public FDA data to make it easier to understand. We are an independent service and are not affiliated with the FDA or any government agency, so please always refer to the official source for the authoritative record — and note the “last synced” date shown on this page, since recall details can change over time.

Who this recall affects

This recall matters to anyone who bought Theophylline Extended-Release Tablets, 100 mg, Rx Only. Even if you feel fine, it's worth checking what you have on hand rather than assuming you were missed.

Distribution listed in the notice: Nationwide within U.S.

What manufacturing quality issue (CGMP) actually means

CGMP stands for Current Good Manufacturing Practice — the FDA's quality rules for how medicines must be made, tested, and documented. A CGMP-related recall means the manufacturing process did not meet those standards. It does not automatically mean the medicine is harmful, but the FDA cannot be confident in its quality, so it is removed from the market.

In this case, the concern applies specifically to Theophylline Extended-Release Tablets, 100 mg, Rx Only from Brandywine Pharmaceuticals, LLC — not to the wider category of products. Similar items from other brands aren't part of this recall.

How to check whether you have it

On medicine bottles, the lot number and expiration date are printed on the pharmacy label or stamped directly on the manufacturer's bottle — often near the bottom edge or on the back. If a pharmacy label covers it, your pharmacist can look up the lot they dispensed.

Compare what you find against the identifying details in this recall: Lot: 405617, Expiry: 03/31/2028

What to do if you already bought it

Do not stop taking a prescribed medicine on your own because of a recall — for many conditions, an interrupted dose carries its own risk.

Instead, check the lot number against the details above and contact your pharmacist, who can confirm what they dispensed and arrange a replacement.

If you've had an unexpected reaction, contact your healthcare provider. Problems can also be reported to the FDA's MedWatch program.

Full recall details

Status
Ongoing
Date reported
November 4, 2026
Recall started
October 6, 2026
Distributed in
PA
What was recalled
Theophylline Extended-Release Tablets, 100 mg, Rx Only, 100-count bottle, Distributed by: Brandywine Pharmaceuticals, LLC, West Chester, PA 19382, NDC: 71321-500-10
Why it was recalled (as stated by the FDA)
CGMP Deviations: interruption in the ongoing stability testing program conducted at a third-party laboratory
How to identify the affected product
Lot: 405617, Expiry: 03/31/2028
Amount recalled
1,620 100-count bottles

What you can do

Check whether any product you have matches the description and codes above. If it does, stop using it and follow the instructions in the official recall notice. When in doubt, contact the company or your local health authority.

Quick answers

Why was Theophylline Extended-Release Tablets, 100 mg, Rx Only recalled?+

According to the FDA: CGMP Deviations: interruption in the ongoing stability testing program conducted at a third-party…

How serious is this recall?+

Class II — moderate. Using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.

What should I do if I have Theophylline Extended-Release Tablets, 100 mg, Rx Only?+

Compare your product against the description and identifying codes on this page. If it matches, stop using it and follow the instructions in the official recall notice — this usually means returning it for a refund or discarding it. When in doubt, contact the company or your local health authority.

Share this recall:PostShareEmail
View the official FDA record →

Opens the U.S. Food and Drug Administration (FDA) data for this recall.

Recall number: D-0110-2027. Information last synced from the FDA on November 22, 2026.

Related recalls